检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

David Spigel,M. Catherine Pietanza,Todd Bauer,Neal Ready,Daniel Morgensztern,Bonnie S. Glisson,Lauren Averett Byers, Melissa Johnson,Howard Burris,Francisco Robert,Tae Han,Sheila Bheddah,Noah Theiss,Sky Watson,Deepan Mathur,Bharathi Vennapusa,Donald Strickland,Hany Zayed,Scott Dylla,Stanford Peng,Ramaswamy Govindan,Charles Rudin

JOURNAL OF THORACIC ONCOLOGY（2017）

引用 1|浏览25
暂无评分
关键词
clinical trial,Rovalpituzumab tesirine,Delta-like protein 3,SCLC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要